Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
NIP header
Health Care Professionals
NIP:
bullet NIP HOME
bullet First time visitor?
bullet About NIP
bullet Data and Statistics
bullet International Efforts
bullet Links to other web sites 
bullet Glossary/ Acronyms 

NIP sub-sites:
bullet ACIP
bullet Flu Vaccine
bullet Immunization Registries
bullet Vaccines for Children Program
bullet CASA (Clinic Assessment Program)
bullet AFIX (Grantee Assessment)
bullet VACMAN
 

NIP Site Search
 
For Immunization Information, call the
CDC-INFO Contact Center:
English and Spanish
800-CDC-INFO
800-232-4636
TTY
888-232-6348

Get Acrobat Reader
Get Adobe Reader
 

Vaccines > Polio
FAQs on Polio Vaccine
Questions and Answers image

Clinical questions & answers 

Related page: Q&As from Providers

General questions:

Vaccine handling, storage & injection technique related:

Vaccine use, recommendations & schedule related:

Contraindications, precautions & adverse events related:


General questions:
  • Why did CDC and ACIP change the polio vaccination schedule to an all-IPV series?

The CDC and ACIP changed the polio schedule in 2000 because the only indigenously acquired polio in the U.S. since 1980 had been due to the vaccine, while there had been no polio cases due to the wild poliovirus. The ACIP determined that the risk-benefit ratio associated with the exclusive use of the OPV for routine immunization had changed because of the rapid progress in global polio eradication efforts. In particular, the benefits of OPV had diminished in importance due to the elimination of wild virus associated poliomyelitis in the Western Hemisphere since 1991 and the reduced threat of poliovirus importation into the U.S.

Conversely, the risk of vaccine-associated poliomyelitis due to OPV, which caused an average of 8-9 reported cases of paralytic polio each year, was judged less acceptable due to the absence of indigenous disease and reduced risk of imported infection.

Consequently, in 1996 the ACIP and CDC recommended a transition policy to increase use of IPV and decrease use of OPV, and in 2000 recommended exclusive use of IPV.

  • Isn't IPV less effective than OPV?

No. The IPV that has been used in the U.S. since 1987 is as effective as OPV for preventing polio in the recipient. After two doses of IPV, 90% or more of recipients have protective antibody levels to all types of poliovirus, and after three doses more than 99% have protective antibodies.

Top of page

Vaccine handling, storage & injection technique related questions:
  • Previously, IPV was recommended to be administered SQ only. Now I've read that it may also be given IM. Is this correct?

IPV is approved for either subcutaneous or intramuscular administration.

Top of page

Vaccine use, recommendations & schedule related questions:
  • After what age is routine polio vaccine no longer recommended?

Routine polio vaccination is not recommended for persons 18 years of age and older who reside in the United States.

  • What is the IPV schedule for unvaccinated children 418 years of age?

The schedule for routine polio vaccination of children 417 years of age is 2 doses of IPV separated by 48 weeks, and a third dose 612 months after the second dose. If an accelerated schedule is needed, three doses separated by at least 4 weeks may be given. Polio vaccine is not routinely administered to persons 18 years of age and older.

  • If a child received 4 doses of IPV before the 2nd birthday, with at least 4 weeks between doses, is a 5th dose necessary?

ACIP recommends that the fourth dose in the polio series be given at school entry (4-6 years of age), mainly to assure long-term protection. But a child who has received a total of four doses of polio vaccine at least 4 weeks apart does not need a fifth dose at school entry.

However, some states mandate a dose of polio vaccine to be administered on or after 4 years of age as a requirement for school entry. In this situation just give a fifth dose at school entry. There is no harm in giving an additional dose.

Top of page

Contraindications, precautions & adverse events related questions:
  • What is the risk of serious reactions following IPV?

There are no serious reactions known to occur following IPV.

Top of page


National Immunization Program (NIP)
NIP Home | Contact Us | Help | Glossary | About | Accessibility

This page last modified on May 3, 2004
This page last reviewed on January 7, 2002

   

Department of Health and Human Services
Centers for Disease Control and Prevention
CDC Home
  |  CDC Search  |  CDC Health Topics A-Z